全文获取类型
收费全文 | 66519篇 |
免费 | 5961篇 |
国内免费 | 3613篇 |
专业分类
耳鼻咽喉 | 745篇 |
儿科学 | 874篇 |
妇产科学 | 669篇 |
基础医学 | 8467篇 |
口腔科学 | 1114篇 |
临床医学 | 7444篇 |
内科学 | 10910篇 |
皮肤病学 | 1102篇 |
神经病学 | 4183篇 |
特种医学 | 3195篇 |
外国民族医学 | 19篇 |
外科学 | 7254篇 |
综合类 | 8916篇 |
现状与发展 | 14篇 |
一般理论 | 10篇 |
预防医学 | 4143篇 |
眼科学 | 1678篇 |
药学 | 6722篇 |
50篇 | |
中国医学 | 2986篇 |
肿瘤学 | 5598篇 |
出版年
2024年 | 122篇 |
2023年 | 728篇 |
2022年 | 1544篇 |
2021年 | 3042篇 |
2020年 | 2167篇 |
2019年 | 2082篇 |
2018年 | 2241篇 |
2017年 | 2024篇 |
2016年 | 2226篇 |
2015年 | 3194篇 |
2014年 | 3761篇 |
2013年 | 3853篇 |
2012年 | 5581篇 |
2011年 | 5829篇 |
2010年 | 4071篇 |
2009年 | 3166篇 |
2008年 | 3970篇 |
2007年 | 3873篇 |
2006年 | 3488篇 |
2005年 | 3401篇 |
2004年 | 2555篇 |
2003年 | 2590篇 |
2002年 | 2192篇 |
2001年 | 1543篇 |
2000年 | 1239篇 |
1999年 | 1121篇 |
1998年 | 645篇 |
1997年 | 614篇 |
1996年 | 403篇 |
1995年 | 466篇 |
1994年 | 332篇 |
1993年 | 210篇 |
1992年 | 330篇 |
1991年 | 252篇 |
1990年 | 210篇 |
1989年 | 199篇 |
1988年 | 150篇 |
1987年 | 148篇 |
1986年 | 141篇 |
1985年 | 69篇 |
1984年 | 53篇 |
1983年 | 29篇 |
1982年 | 30篇 |
1981年 | 21篇 |
1980年 | 18篇 |
1979年 | 28篇 |
1977年 | 14篇 |
1974年 | 18篇 |
1973年 | 17篇 |
1969年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
用放射免疫法对144例脑梗塞患者及24例对照者脑脊液中β—内啡肽(β—EP)、亮脑啡肽(LEK)、强啡肽A_(1-13)(D_(yn)A_(1-13))含量进行检测,结果显示脑梗塞急性期3天内β—EP、LEK含量较对照组显著增高.D_(yn)A_(1-13)较对照组显著降低,一周后逐渐接近或达到对照组水平。同时也发现基底节区脑梗塞患者脑脊液中β-EP、LEK较其它部位梗塞为高,D_(yn)A_(1-13)较其它部位梗塞为低,与对照组相比差异显著。提示脑脊液中二种阿片肽含量变化与脑梗塞时缺血性应激反应有关。三者不平衡变化,参与了急性脑梗塞时缺血性脑水肿等病理生理过程。也提示脑梗塞急性期(尤其3天内)适量应用阿片受体拮抗剂或激动剂,有利于减轻缺血性脑水肿,缓解神经受损症状。 相似文献
103.
四氧嘧啶诱发糖尿病大鼠血管紧张素的变化 总被引:1,自引:0,他引:1
实验观察了四氧嘧啶诱发糖尿病大鼠连续饲养110d后体内肾素一血管紧张素系统的变化。结果表明,血浆和心脏的血管紧张素Ⅱ含量无明显变化,而肾脏的AngⅡ含量却明显低于正常对照组。另外,心脏的心钠素(ANP)含量在糖尿病大鼠与正常对照组之间无差别,血中的糖化血红蛋白含量基本无变化。上述结果表明,糖尿病大鼠早期心脏可能无明显损伤,而肾脏的肾素一血管紧张素系统活性降低。 相似文献
104.
Pamela H. Orr Victor Dong Marlis L. Schroeder Malcolm R. Ogborn 《Pediatric nephrology (Berlin, Germany)》1995,9(5):612-613
P1 blood group positivity has been postulated as a host factor which may provide protection against the development of post-enteropathic hemolytic uremic syndrome (HUS). In this study, blood group status in 20 Inuit survivors ofEscherichia coli 0157: H7-associated HUS was compared with age-and sex-matched controls from the same community who had experienced uncomplicated diarrheal illness due to the same pathogen. Of 20 HUS survivors, 6 were P1 antigen positive compared with 8 of the 20 controls (P=0.7). We conclude that P1 antigen positivity was not protective against HUS in this population. Further studies of this condition to clarify the role of host factors in verotoxin-induced endothelial damage are indicated. 相似文献
105.
106.
PURPOSETo evaluate the efficacy, safety, and results of direct thrombolytic therapy in intracranial dural sinus thrombosis by infusion of alteplase (recombinant tissue plasminogen activator).METHODSNine patients were treated during a 2-year period for intracranial dural sinus thrombosis. A microcatheter was placed directly into the thrombus in the dural sinus via the transfemoral route. Thrombolysis was initiated with a rapid injection of 10 mg of alteplase over 10 minutes, followed in 3 hours by a continuous infusion of 50 mg, then a continuous infusion at 5 mg per hour until complete thrombolysis or a total dose of 100 mg per day had been reached. Repeat thrombolysis was tried the following day if complete recanalization did not occur at 100 mg per day.RESULTSSuccessful recanalization with improvement of symptoms was achieved in all cases. Time required for complete thrombolysis was between 8 and 43 hours. The total dose of alteplase ranged from 50 to 300 mg. Complications of a small intrapelvic hemorrhage and oozing at a femoral puncture site occurred in separate cases, but were not related to the amount of infused alteplase. MR venograms obtained 1 to 4 weeks after the procedure showed no evidence of reocclusion of the dural sinuses.CONCLUSIONDirect fibrinolytic therapy with alteplase is safe, fast, and effective in treating dural sinus thrombosis. However, to prevent hemorrhagic complications, further studies are required to determine its optimal dose and proper rate of administration. 相似文献
107.
Jin Woo Kim M.D. Ho Shik Kim M.D. In Kyung Kim M.D. Mee Ran Kim M.D. Eun Young Cho B.S. Heung Kee Kim M.D. Joon Mo Lee M.D. Sung Eun Namkoong M.D. 《Gynecologic oncology》1998,69(3):230-236
Transforming growth factor-β1 (TGF-β1) is known to be a potent growth inhibitor for many cell types, including most epithelial cells. In skin keratinocytes, TGF-β1 has been shown to inhibit growth and to rapidly reduce c-mycexpression. However, the molecular mechanism of TGF-β1 action on cell growth of cervical carcinoma has not yet been elucidated. We thus assessed the effect of TGF-β1 on the growth of cervical carcinoma cell lines. Two cervical squamous carcinoma cell lines, CUMC-3 and CUMC-6, were incubated with varying concentrations of TGF-β1, and growth inhibition was evaluated with tetrazolium-based colorimetric assay. After culture in TGF-β1 for 24 h, inhibition of growth was detected in a dose-dependent manner at concentrations of 0.1–10 ng/ml in both cell lines. This effect of TGF-β1 on cultured carcinoma cells was associated with apoptotic process including oligonucleosomal ladder DNA and apoptotic body formations. Northern blot analysis revealed c-mycmRNA expression was suppressed by 10 ng/ml of TGF-β1 following 3 h of treatment in both cell lines. Western blot analysis showed that the level of p27Kip1protein was increased after TGF-β1 treatment in both cell lines. These results suggest that the mechanisms by which TGF-β1 inhibits the growth of cervical carcinoma are complex and may include effects on down-regulation of c-mycgene, and overexpression of p27Kip1protein. 相似文献
108.
Influence of Preparation Factors on the Sustained Release of Nifedipine from Eudragit RL/RS Microspheres 总被引:1,自引:0,他引:1
用乳剂—溶剂挥发法制备硝苯地平的丙烯酸树脂缓释微球。微球中药物的释放速度随丙烯酸树脂EudragitRL/RS比率的增加以及制备时搅拌速率的增加而增大,随内相聚合物浓度的增加及微球粒径的增加而减小,释药50%所需时间与微球粒径呈良好线性。微球的释药速率也随药物含量的增加(从4.2%到16.7%)而增大,并快于药物结晶的溶解速率,但药物含量达26.6%时,微球释药速率明显下降并低于药物结晶的溶解速率。用差热分析和X射线衍射分析证明,药物含量为4.2,9.4和16.7%的微球中药物完全是以非晶态分散的,而含药26.6%的微球中有药物结晶存在。不同微球释药低于70%时,释放方式均符合Higuchi时间平方根方程。 相似文献
109.
巢式PCR检测先天性心脏病心脏石蜡标本中B19病毒的感染 总被引:2,自引:0,他引:2
目的:探讨微小病毒B19与先天性心脏病(CHD)的相关性及可能致畸机理。方法:采用病例对照研究,病例组为29例CHD尸解心脏组织,对照组为30例同期非先天性畸形尸解心脏组织,应用巢式PCR扩增B19-DNA,单纯疱疹病毒(HSV),兔弓形虫(TOX),巨细胞病毒(CMV),结果:29例CHDB19-DNA5例阳性,全瓿对照组为均阴性(P=0.0237),HSV,TOX两组中均阴性,CMV在两组中均 相似文献
110.
采集23名产妇的脐带血和8名正常成人的外周血制备LAK细胞,随机分为4组,在培养第3,5,7,14天,分别利用MTT法和^125I-UdR释放法对4组LAK细胞的增殖力和杀伤活性进行了测定,同时用细胞毒方法测定培养7天的LAK细胞的免疫表型。结果发现,在不同培养时间,脐血来源的LAK细胞增殖力显著高于成人血LAK细胞(P〈0.05或P〈0.01),成人血清组,脐血血清组,红细胞组LAK细胞增殖力有 相似文献